Trial intelligence / Profile preview

FIT4KID

NCT04741646Phase 2Recruiting

Sponsor
University of California, Los Angeles
Start
Jun 2022
Primary completion
Oct 2027
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of ferric citrate in chronic kidney disease (CKD), sponsored by University of California, Los Angeles. Started Jun 2022; status: recruiting.

02

Drugs

ferric citrate
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT04741646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04741646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call